Institutional investors in CG Oncology, Inc. (NASDAQ:CGON) must be dismayed after prices dropped by 13% last week
Analyzing analyst forecasts and ownership structure can aid in evaluating a company's future performance. For instance, CG Oncology, Inc. is predominantly owned by institutions, with Decheng Capital LLC being the largest shareholder. Insiders also hold a significant stake, indicating alignment with shareholders.